Project
Nanotechnologies - Total, encapsulated, and free drug quantitation in doxorubicin hydrochloride liposomal formulations using reversed phase high performance liquid chromatography (RP-HPLC)
Begin
2025-05-09
Planned document number
ISO/AWI TS 3181
Responsible national committee
NA 062-08-17-03 UA - Health and environmental aspects
Responsible international committee
ISO/TC 229/JWG 2 - Joint ISO/TC 229 - IEC/TC 113 WG :Measurement and characterization
